4.0 Article

Modulated multiparametric phosphoflow cytometry in hematological malignancies: technology and clinical applications

Journal

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
Volume 23, Issue 3, Pages 319-331

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.beha.2010.07.002

Keywords

phosphoflow; multiparameter flow cytometry; diagnostic, signal transduction; biological characterization; standardization; leukemia; pharmacodynamics

Categories

Ask authors/readers for more resources

The advent of modulated multiparameter phosphoflow cytometry allows insight into the complexity of signal transduction networks in distinct cell subsets within a complex tissue sample. The application of this technology to hematopoietic malignancies can reveal pathogenic signaling profiles in intact tumor cells. Here, we review recent studies demonstrating the advantages and utility of this technology to inform the biological characterization of tumor cells and its applications to clinical medicine and drug development. Further, we discuss standardization and quality control approaches necessary for the adoption of this technique into clinical flow cytometry laboratories. (C) 2010 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available